Elevation Oncology Inc. (ELEV)
NASDAQ: ELEV
· Real-Time Price · USD
0.38
0.06 (18.79%)
At close: Jun 09, 2025, 3:59 PM
18.79% (1D)
| Bid | 0.38 |
| Market Cap | 22.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.99M |
| EPS (ttm) | -0.81 |
| PE Ratio (ttm) | -0.47 |
| Forward PE | -0.73 |
| Analyst | Hold |
| Ask | 0.39 |
| Volume | 26,040,153 |
| Avg. Volume (20D) | 1,315,719 |
| Open | 0.39 |
| Previous Close | 0.32 |
| Day's Range | 0.38 - 0.40 |
| 52-Week Range | 0.22 - 3.66 |
| Beta | 1.45 |
About ELEV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELEV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELEV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
Elevation Oncology shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
-12.24%
Elevation Oncology shares are trading lower after the company reported worse-than-expected Q1 EPS results.
